A review of the effects of transurethral microwave thermotherapy (TUMT) for lower urinary tract symptoms (LUTS) in men with benign prostate hyperplasia

1. Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH. Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical “Aging Male” symptoms? Results of the “Cologne Male Survey”. Eur Urol 2003;44(5):588-94.10.1016/S0302-2838(03)00358-0 Search in Google Scholar

2. de la Rosette JJ, Laguna MP, Gravas S, de Wildt MJAM. Transurethral microwave thermotherapy: the gold standard for minimally invasive therapies or patients with benign prostatic hyperplasia? J Endourol 2003;17(4):245-51. Search in Google Scholar

3. Walmsley K, Kaplan SA. Transurethral microwave thermotherapy for benign prostate hyperplasia: separating truth from marketing hype. J Urol 2004;172:1249-55. doi: 10.1097/01.ju.0000129967.30558.ca.10.1097/01.ju.0000129967.30558.ca Search in Google Scholar

4. Hoffman RM, Monga M, Elliot SP, Mac Donald R, Langsjoen J, et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane database of systematic reviews. The Cochrane Library; 2012. p. 9.10.1002/14651858.CD004135.pub3 Search in Google Scholar

5. Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004;46(5):547-54.10.1016/j.eururo.2004.07.016 Search in Google Scholar

6. Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? BJU Int 1999;83(3):227-37. Search in Google Scholar

7. Madersbacher S, Kratzik C, Susani M, Marberger M. Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. J Urol 1994;152(6 Pt 1):1956-60.10.1016/S0022-5347(17)32278-4 Search in Google Scholar

8. Nørby B, Nielsen HV, Frimodt-Møller PC. Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs. transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia. BJU Int 2002;90(9):853-62.10.1046/j.1464-410X.2002.03031.x Search in Google Scholar

9. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP) – incidence, management, and prevention. Eur Urol 2006;50(5):969-80.10.1016/j.eururo.2005.12.042 Search in Google Scholar

10. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008;180(1):246-9.10.1016/j.juro.2008.03.058 Search in Google Scholar

11. Yu X, Elliott SP, Wilt TJ, McBean AM. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol 2008;180(1):241-5.10.1016/j.juro.2008.03.039 Search in Google Scholar

12. Tzortzis V, Gravas S, de la Rosette JJMCH. Minimally invasive surgical treatments for benign prostatic hyperplasia Eur Urol Suppl 2009;8(6):513-22. Search in Google Scholar

13. Dixon C, Rijo Cedano E, Pacik D, Vit V, Varga G, Wagrell L, et al. Transurethral water vapor therapy for BPH; initial clinical results of the first in man trial and Rezum I pilot study. Eur Urol Suppl 2013;12:e631.10.1016/S1569-9056(13)61114-8 Search in Google Scholar

14. Chung A, Woo HH. What’s truly minimally invasive in benign prostatic hyperplasia surgery? Curr Opin Urol 2014;24(1):36-41. Search in Google Scholar

15. Faber K, de Abreu AL, Ramos P, Aljuri N, Mantri S, Gill I, et al. Image-guided robot-assisted prostate ablation using water jet-hydrodissection: initial study of a novel technology for benign prostatic hyperplasia. J Endourol 2015;29(1):63-9.10.1089/end.2014.0304 Search in Google Scholar

16. Schade GR, Styn NR, Hall TL, Roberts WW. Endoscopic assessment and prediction of prostate urethral disintegration after histotripsy treatment in a canine model. J Endourol 2012;26(2):183-9.10.1089/end.2011.0349 Search in Google Scholar

17. Tabatabaei S, Zangi M. Outpatient surgery for lower urinary tract symptoms/benign prostatic hyperplasia: truth or myth? Curr Opin Urol 2015;25:27(1)-31. doi: 10.1097/MOU.0000000000000127.10.1097/MOU.0000000000000127 Search in Google Scholar

18. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, et al. The longterm effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyper-plasia. N Engl J Med 2003;349(25):2387-98.10.1056/NEJMoa030656 Search in Google Scholar

19. Aagaard MF, Niebuhr MH, Jacobsen JD, Nielsen KK. Transurethral microwave thermotherapy treatment of chronic urinary retention in patients unsuitable for surgery. Scand J Urol 2014;48:290-4.10.3109/21681805.2013.840857 Search in Google Scholar

20. Ravery V. Transurethral microwave thermotherapy v transurethral resection of prostate. J Endourol 2000;14:693-6. doi: 10.1089/end.2000.14.693.10.1089/end.2000.14.693 Search in Google Scholar

21. Brehmer M, Baba S: Transurethral microwave thermotherapy, how does it work? J Endourol 2000;14(8):611-5.10.1089/end.2000.14.611 Search in Google Scholar

22. Yerushalmi A, Fishelovitz Y, Singer D, Reiner I, Arielly J, Abramovici Y, et al. Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia. J Urol 1985;133(5):873-6.10.1016/S0022-5347(17)49270-6 Search in Google Scholar

23. Veselys S, Muller M, Knutson T, Peeker R, Hellström M, Dahlstrand C. Tranurethral microwave thermotherapy of the prostate – Evaluation with MRI and analysis of parameters relevant to outcome. Scand J Urol Nephrol 2008;42(1):53-8.10.1080/0036559070154707618210336 Search in Google Scholar

24. Gravas S, Cornu JN, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C, et al. Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). EAU Guidelines; 2019. Search in Google Scholar

25. Wilhelm K. Benign prostatic hyperplasia: possibilities of microwave thermotherapy. Der Urologe 2018;57:1366-9. doi: 10.1007/s00120-018-0779-z.10.1007/s00120-018-0779-z30259061 Search in Google Scholar

26. Ahmed M, Bell T, Lawrence WT, Ward JP, Watson GM. Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyper-plasia: a randomized, controlled, parallel study. Br J Urol 1997;79(2):181-5.10.1046/j.1464-410X.1997.02667.x Search in Google Scholar

27. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003;170(2 Pt 1):530-47.10.1097/01.ju.0000078083.38675.7912853821 Search in Google Scholar

28. Lerner LB, McVary, KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al: Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline part I, initial work-up and medical management. J Urol 2021;206(4):818-26. doi: 10.1097/JU.0000000000002183.10.1097/JU.000000000000218334384237 Search in Google Scholar

29. Lerner LB, McVary, KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al: Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline part II, surgical evaluation and treatment. J Urol 2021;206(4):806-17. doi: 10.1097/JU.0000000000002184.10.1097/JU.000000000000218434384236 Search in Google Scholar

30. Franco JVA, Garegnani L, Escobar Liquitay CM, Borofsky M, Dahm P. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. World J Mens Health 2021;39(6):CD004135. doi: 10.1002/14651858.CD004135.pub4.10.1002/14651858.CD004135.pub4823648434180047 Search in Google Scholar

31. Abrams P, Schulman CC, Vaage S. Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic ‘obstruction’ (symptomatic BPH). The European Tamsulosin Study Group. Br J Urol 1995;76(3):325-36.10.1111/j.1464-410X.1995.tb07709.x7551841 Search in Google Scholar

32. Perlmutter AP, Perachino M. Mechanism of microwave thermotherapy. World J Urol 1998;16(2):82-8.10.1007/s00345005003112073234 Search in Google Scholar

33. D’Ancona FCH, Francisca EAE, Witjes WPJ, Welling L, Debruyne FMJ, de la Rosette JJ. High energy thermotherapy versus transurethral resection in the treatment of benign prostatic hyperplasia: results of a prospective randomized study with 1 year of followup. J Urol 1997;158:120-5. doi: 10.1097/00005392-199707000-00035.10.1097/00005392-199707000-000359186336 Search in Google Scholar

34. Mattiasson A, Wagrell L, Schelin S, Nordling J, Richthoff J, Magnusson B, et al. Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study. Randomized Controlled Trial. Urology 2007;69(1):91-6. doi: 10.1016/j.urology.2006.08.1115.10.1016/j.urology.2006.08.111517270624 Search in Google Scholar

35. Dahlstrand C, Geirsson G, Fall M, Pettersson S. Transurethral microwave thermotherapy versus transurethral resection for benign prostatic hyperplasia: preliminary results of a randomized study. Eur Urol 1993;23(2):292-8. doi: 10.1159/000474615.10.1159/0004746157683989 Search in Google Scholar

36. Ogden CW, Reddy R, Johnson H, Ramsay JW, Carter SS. Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction. Lancet 1993;341(8836):14-7.10.1016/0140-6736(93)92482-9 Search in Google Scholar

37. Nawrocki JD, Bell TJ, Lawrence WT, Ward JP. A randomized controlled trial of transurethral microwave thermotherapy. Clinical Trial Br J Urol 1997;79(3):389-93. doi: 10.1046/j.1464-410x.1997.21515.x.10.1046/j.1464-410X.1997.21515.x Search in Google Scholar

38. Ekstrand V, Westermark S, Wiksell H, Bergman B, Cronwall K. Long-term clinical outcome of transurethral microwave thermotherapy (TUMT) 1991–1999 at Karolinska Hospital, Sweden. Scand J Urol Nephrol 2002;36(2):113-8. doi: 10.1080/003655902753679391.10.1080/003655902753679391 Search in Google Scholar

39. de La Rosette JJ, De Wildty MJ, Alvizatos, G. Transurethral microware thermotherapy (TUMT) in benign prostatic hyperplasia: placebo versus TUMT. Urology 1994;44(1):58-63.10.1016/S0090-4295(94)80010-3 Search in Google Scholar

40. Aoun F, Quentin Marcelis Q, Roumeguère T. Minimally invasive devices for treating lower urinary tract symptoms in benign prostate hyperplasia: technology update. Res Rep Urol 2015;7:125-36. Search in Google Scholar

41. Saitz TR, Conlin MJC, Tessier CD, Hatch TR. Safety and efficaccy of transurethral microvawe therapy in high-risk catheter-dependent men. Turk J Urol 2019;45(1):27-30.10.5152/tud.2018.09622634257630461379 Search in Google Scholar

42. Seftel A, Rosen R, Kuritzky L. Physician perceptions of sexual dys-function related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications. Int J Impot Res 2007;19(4):386-92.10.1038/sj.ijir.390154017377613 Search in Google Scholar

43. Frieben RW, Lin HC, Hinh PP, Berardinelli F, Canfield SE, Wang R, et al. The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review. Asian J Androl 2010;12(4):500-8.10.1038/aja.2010.33373936720473318 Search in Google Scholar

44. Roehrborn CG, Nuckolls JG, Wei JT, Steers W. The benign prostatic hyper-plasia registry and patient survey: study design, methods and patient baseline characteristics. BJU Int 2007;100(4):813-9.10.1111/j.1464-410X.2007.07061.x17822462 Search in Google Scholar

45. Lindau ST, Schumm LP, Laumann EO, Levinson W, O’Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007;357(8):762-74.10.1056/NEJMoa067423242674317715410 Search in Google Scholar

46. Abrams P. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2020. Letter. J Urol 2021;205(3):938. doi: 10.1097/JU.0000000000001558.10.1097/JU.000000000000155833315535 Search in Google Scholar

47. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Hendersson WG. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995;332(2):75-9. doi: 10.1056/NEJM199501123320202.10.1056/NEJM1995011233202027527493 Search in Google Scholar

48. Oka AAG, Duarsa GKD, Novianti PA, Mahadewa TGB, Ryalino C. The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia. Res Rep Urol 2019;11:91-6.10.2147/RRU.S189414648986631114764 Search in Google Scholar

49. Storsky M, Jaeger I. BPH procedural treatment: the case for value based pay for performance. Adv Urol 2008;2008:954721. Search in Google Scholar

50. Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FDR, Fourcade R, et al. The prevalence of male urinary incontinence in four centres: the UREPIK study. BJU Int 2003;92(9):943-7.10.1111/j.1464-410X.2003.04526.x Search in Google Scholar

51. DiSantostefano RI, Biddle AK, Lavelle JP. The long term cost effectiveness of treatment for benign prostatic hyperplasia. Pharmacoeconomics 2006;24(2):171-91.10.2165/00019053-200624020-0000616460137 Search in Google Scholar

52. Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 2015;67(6):1066.10.1016/j.eururo.2014.06.01724972732 Search in Google Scholar

53. Gravas (Chair) S, Cornu JN, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C, et al. Management of non-neurogenic male LUTS. European Association of Urology. https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts (12.04.2021). Search in Google Scholar

54. Chen S, Zhu L, Cai J, Zheng Z, Ge R, Wu M, et al. Plasmakinetic enucleation of the prostate compared with open prostatectomy for prostates larger than 100 grams: a randomized noninferiority controlled trial with long-term results at 6 years. Eur Urol 2014;66(2014):284.10.1016/j.eururo.2014.01.01024502959 Search in Google Scholar

55. Tan A, Liao C, Mo Z, Cao Y. Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg 2007;94(10):1201-8.10.1002/bjs.591617729384 Search in Google Scholar